In a study comparing HBV reactivation between patients with low and high HBV DNA loads, who were undergoing anti-PD-1 blockade treatment, similar incidences of HBV reactivation and HBV-associated hepatitis were observed [30]. This evidence concerns the gene PDCD1 and hepatitis A virus infection.